Form 4: Leap Therapeutics Insider Reports Stock Transaction
Insider Transaction (Form 4)
Winklevoss Capital Fund, LLC and 4 others reported changes in beneficial ownership of Leap Therapeutics, Inc. common stock on August 17, 2026.
Summary
- In-the-money derivative exercise: acquired 16,570,852 Common Stock at $0.00 ($16,571) on August 17, 2026; holds 24,854,613 after (Indirect).
- In-the-money derivative exercise: disposed of 16,570,852 Pre-Funded Warrant (Right to Buy) at $0.52 ($8,610,215) on August 17, 2026; holds 58,877,766 after (Indirect).
- Other acquisition/disposition: acquired 43,290,042 Pre-Funded Warrant (Right to Buy) at $0.77 ($33,333,332) on August 17, 2026; holds 102,167,808 after (Indirect).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Winklevoss Capital Fund, LLC — 10% owner
Winklevoss Treasury Investments, LLC — 10% owner
Tyler Howard Winklevoss — 10% owner
Cameron Howard Winklevoss — 10% owner
Winklevoss Capital Management, LLC — 10% owner
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-17 | In-the-money derivative exercise | Common Stock | 16,570,852 | $0 | $16.6K | 24,854,613 |
| 2026-08-17 | In-the-money derivative exercise | Pre-Funded Warrant (Right to Buy) | 16,570,852 | $1 | $8.6M | 58,877,766 |
| 2026-08-17 | Other acquisition/disposition | Pre-Funded Warrant (Right to Buy) | 43,290,042 | $1 | $33.3M | 102,167,808 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-17 | In-the-money derivative exercise (16,570,852 shares) |
| 2026-08-17 | In-the-money derivative exercise (16,570,852 shares) |
| 2026-08-17 | Other acquisition/disposition (43,290,042 shares) |
Keywords
insider transaction, Form 4, CYPH, CYPHERPUNK TECHNOLOGIES INC., neutral, Winklevoss Capital Fund, LLC, Winklevoss Treasury Investments, LLC, Tyler Howard Winklevoss, Cameron Howard Winklevoss, Winklevoss Capital Management, LLC
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.